These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29087153)

  • 21. Management of diabetes mellitus in chronic kidney disease.
    Garla V; Kanduri S; Yanes-Cardozo L; Lién LF
    Minerva Endocrinol; 2019 Sep; 44(3):273-287. PubMed ID: 31112029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal medication dosing in patients with diabetes mellitus and chronic kidney disease.
    MacCallum L
    Can J Diabetes; 2014 Oct; 38(5):334-43. PubMed ID: 25284697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral antidiabetics use among diabetic type 2 patients with chronic kidney disease. Do nephrologists take account of recommendations?
    Muller C; Dimitrov Y; Imhoff O; Richter S; Ott J; Krummel T; Bazin-Kara D; Chantrel F; Hannedouche T; ;
    J Diabetes Complications; 2016; 30(4):675-80. PubMed ID: 26900098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consensus statement on insulin therapy in chronic kidney disease.
    Rajput R; Sinha B; Majumdar S; Shunmugavelu M; Bajaj S
    Diabetes Res Clin Pract; 2017 May; 127():10-20. PubMed ID: 28315574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Newer anti - diabetic therapies and chronic kidney disease].
    Di Lullo L; Ronco C; Barbera V; Cozzolino M; Santoboni F; Villani A; De Pascalis A; Bellasi A
    G Ital Nefrol; 2017; 34(1):. PubMed ID: 28177092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
    Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
    Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic kidney disease in type 2 diabetic patients followed-up by primary care physicians in Switzerland: prevalence and prescription of antidiabetic drugs.
    Lamine F; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2016; 146():w14282. PubMed ID: 26922155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological management of type 2 diabetes mellitus in patients with CKD.
    Hamilton CA
    J Ren Care; 2012 Feb; 38 Suppl 1():59-66. PubMed ID: 22348365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Consensus document on treatment of type 2 diabetes in patients with chronic kidney disease].
    Gómez-Huelgas R; Martínez-Castelao A; Artola S; Górriz JL; Menéndez E;
    Nefrologia; 2014; 34(1):34-45. PubMed ID: 24611186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
    Snyder RW; Berns JS
    Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing diabetes in hospitalized patients with chronic kidney disease.
    Iyer SN; Tanenberg RJ
    Cleve Clin J Med; 2016 Apr; 83(4):301-10. PubMed ID: 27055204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oral hypoglycemic drugs in chronic kidney disease: which limitations in the clinical setting].
    Granata A; Insalaco M; Di Nicolò P; Scarfia VR; Russo L; D'anna G; Lentini P; Fiorini F; Fatuzzo P
    G Ital Nefrol; 2014; 31(1):. PubMed ID: 24671840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of hyperglycemia in patients with chronic kidney disease.
    Aires Neto P; Gomes HV; Campos M
    J Nephrol; 2013; 26(4):629-35. PubMed ID: 23807643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of type 2 diabetes mellitus in chronic kidney disease.
    Maffioli P; Derosa G
    Curr Med Res Opin; 2015 Jan; 31(1):95-7. PubMed ID: 25325220
    [No Abstract]   [Full Text] [Related]  

  • 35. Renal function markers and metformin eligibility.
    Tavares Bello C; Castro Fonseca R; Sousa Santos F; Sequeira Duarte J; Azinheira J; Vasconcelos C
    Minerva Endocrinol; 2018 Sep; 43(3):246-252. PubMed ID: 28565889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Achieving glycemic control: cornerstone in the treatment of patients with multiple metabolic risk factors.
    Spellman CW
    J Am Osteopath Assoc; 2009 May; 109(5 Suppl):S8-S13. PubMed ID: 19451256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.
    Cerveny JD; Leder RD; Weart CW
    Ann Pharmacother; 1998 Sep; 32(9):896-905. PubMed ID: 9762378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel hypoglycaemic agents: considerations in patients with chronic kidney disease.
    Game F
    Nephron Clin Pract; 2014; 126(1):14-8. PubMed ID: 24434725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review.
    Sloan L; Cheng AYY; Escalada J; Haluzík M; Mauricio D
    Diabetes Obes Metab; 2024 Apr; 26(4):1157-1170. PubMed ID: 38225217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.